Erythromycin-13C,d3 is an isotopically labeled form of erythromycin, a widely used antibiotic for treating a variety of bacterial infections. This specific compound is enhanced with a carbon-13 (13C) isotope and three deuterium (d3) atoms. The incorporation of these isotopes significantly improves the analytical detection and quantification of the drug in biological and environmental samples using mass spectrometry and nuclear magnetic resonance (NMR) techniques. Erythromycin-13C,d3 is invaluable for research in pharmacokinetics, allowing for detailed studies on the drug’s metabolism and distribution in the body. It also aids in the study of drug-residue analysis in food products and other biological materials, providing crucial data for ensuring safety and compliance with regulations.
| Catalog Number | R009399 |
| CAS Number | 959119-26-7 |
| Synonyms | E-Base-13C,d3; E-Mycin-13C,d3; Erytromycin A-13C,d3; Aknemycin-13C,d3; Aknin-13C,d3; Eemgel-13C,d3; Ery-Derm-13C,d3; Erymax-13C,d3; Ery-Tab-13C,d3; Erythromid-13C,d3; ERYC-13C,d3; |
| Molecular Formula | C₃₆¹³CH₆₄D₃NO₁₃ |
| Purity | 95% |
| Storage | -20°C |
| IUPAC Name | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-[methyl(trideuterio(113C)methyl)amino]oxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| InChI | InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1/i11+1D3 |
| InChIKey | ULGZDMOVFRHVEP-ZZKXWFBHSA-N |
| SMILES | [2H][13C]([2H])([2H])N(C)[C@H]1C[C@H](O[C@H]([C@@H]1O)O[C@@H]2[C@H]([C@@H]([C@H](C(=O)O[C@@H]([C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]2(C)O)C)C)O)(C)O)CC)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)C |
